コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ronchiolitis, cytomegalovirus hepatitis, and chorioamnionitis).
2 scular development in the preterm exposed to chorioamnionitis.
3 Recent studies suggest a possible role of chorioamnionitis.
4 s and included cesarean section and clinical chorioamnionitis.
5 demiological and pathological studies of GBS chorioamnionitis.
6 nes, and clinical and histological bacterial chorioamnionitis.
7 ], 2.7-31.0), as was a clinical diagnosis of chorioamnionitis.
8 re in a patient with preterm labor and acute chorioamnionitis.
9 ic approach to prevent fetal consequences of chorioamnionitis.
10 opioid naive mothers, excluding Infants with chorioamnionitis.
11 al aspirates from preterm infants exposed to chorioamnionitis.
12 ses likely contribute to the pathogenesis of chorioamnionitis.
13 used uterine inflammation, but without overt chorioamnionitis.
14 subsequent neurologic injury associated with chorioamnionitis.
15 ew well in amniotic fluid, there was minimal chorioamnionitis.
16 diseases, many of which are associated with chorioamnionitis.
17 resent and affect human placenta in cases of chorioamnionitis.
18 tal circulation distinguishes VUE from acute chorioamnionitis.
19 (p < 0.05), but not in maternal plasma with chorioamnionitis.
20 and histologic necrotizing acute and chronic chorioamnionitis.
21 59 to 0.03]; aRR, 0.91 [95% CI, 0.82-1.02]), chorioamnionitis (0.5% vs 0.5%; aRD, -0.04 per 100 indiv
22 (95% Confidence Interval [CI] 1.8%-6.8%) for chorioamnionitis, 1.6% (95% CI 0.9%-2.5%) for endometrit
24 philia in the patient with preterm and acute chorioamnionitis, a proven bacterial laboratory contamin
25 of cognitive impairment as compared with no chorioamnionitis (adjusted odds ratio [OR], 2.38 [95% CI
26 as compared with histological plus clinical chorioamnionitis (adjusted OR, 0.68 [95% CI, 0.52 to 0.8
27 of membranes (RR, 1.00; 95% CI, 0.94-1.06), chorioamnionitis (adjusted RR, 1.03; 95% CI, 0.90-1.18),
30 ancy-related complications (preeclampsia and chorioamnionitis) alter their therapeutic potential.
31 s and if their functions were altered during chorioamnionitis, an infectious pathology of the placent
35 itive association was found between clinical chorioamnionitis and cerebral palsy (RR, 4.7; 95% CI, 1.
36 ween clinical (n = 19) or histologic (n = 7) chorioamnionitis and cerebral palsy or cPVL in both pret
38 ssociation between histological and clinical chorioamnionitis and cognitive, behavioral, and neurodev
39 r intra-amniotic infection, fetal infection, chorioamnionitis and fetal pathology at 72 hours post-in
40 ely 80% gestation in rhesus monkeys to cause chorioamnionitis and FIRS that is similar in human patho
41 illus was decreased at birth in infants with chorioamnionitis and in preterm infants who subsequently
43 hogen that causes septicemia, meningitis and chorioamnionitis and is associated with high mortality.
44 of these associations, except for those with chorioamnionitis and labor lasting less than 4 hours.
45 developed to assess the association between chorioamnionitis and outcomes while controlling for impo
46 One pattern, characterized by histologic chorioamnionitis and placental microbe recovery, was ass
50 implicates S. aureus as an emerging cause of chorioamnionitis and premature rupture of membranes, whi
51 We found that both infants with histological chorioamnionitis and rat pups challenged by LPS/HI have
53 te a distinct contribution of betaH/C to GBS chorioamnionitis and subsequent fetal infection in vivo
54 were associated with premature birth, acute chorioamnionitis, and elevated proinflammatory cytokines
55 terleukin-6 levels in their AF, histological chorioamnionitis, and funisitis and delivered neonates w
56 etal and utero-placental tissues, grading of chorioamnionitis, and placental gene expression of IL-1a
57 rth, preterm premature rupture of membranes, chorioamnionitis, and small for gestational age among in
58 Birth weight <750 g, gestation <25 weeks, chorioamnionitis, and vaginal delivery were all strongly
59 preterm labor (aOR 1.55 [95% CI 1.36-1.76]), chorioamnionitis (aOR 1.45 [95% CI 1.15-1.82]), postpart
65 rate the chorioamniotic membranes in chronic chorioamnionitis (CCA), a placental lesion considered to
68 ity of the tissues sectioned from women with chorioamnionitis compared to those experiencing normalte
69 antly increased in all the layers of FM with chorioamnionitis, compared with no-chorioamnionitis subj
71 nterleukin-6 expression levels in DCs during chorioamnionitis could be pivotal in skewing decidual mo
74 comparing clinical outcomes of patients with chorioamnionitis, endometritis, or septic abortion recei
75 ore of these infections after randomisation: chorioamnionitis, endometritis, perineal or caesarean wo
76 and neutrophil-driven inflammation in acute chorioamnionitis exemplify pathological immune activatio
77 e findings increase our understanding of how chorioamnionitis-exposed preterm infants may respond to
78 lts included varying definitions of clinical chorioamnionitis, extent of blinding in determining expo
79 oup B Streptococcus [GBS]) is a precursor to chorioamnionitis, fetal infection, and neonatal sepsis,
80 ract, has been implicated in contributing to chorioamnionitis, fetal morbidity, and fetal mortality.
82 implications for preterm infants exposed to chorioamnionitis for both responses to lung injury and p
90 istent findings linking placental histologic chorioamnionitis (HCA) and preterm delivery may result f
94 n the amnion and chorion define histological chorioamnionitis (HCA), a condition linked to spontaneou
95 aride (LPS) challenge to induce experimental chorioamnionitis in a prenatal rhesus macaque (Macaca mu
96 e of Candida glabrata sepsis associated with chorioamnionitis in an in vitro fertilization-assisted p
99 was associated with histologically confirmed chorioamnionitis in moderate/late preterm and term place
100 nonhuman primate model of an early stage of chorioamnionitis in order to determine the time course a
102 nts pulmonary hypertension in a rat model of chorioamnionitis-induced BPD caused by antenatal inflamm
103 Together, these results suggest that the chorioamnionitis-induced IL-1/IL-17 axis is involved in
104 , 95% CI 7.3-963.7), 6 were admitted and had chorioamnionitis (inflammation of the foetal membranes)
108 e, recreational drug exposure, preeclampsia, chorioamnionitis, intrapartum maternal fever, emergency
116 neous rupture of membranes, whereas an acute chorioamnionitis is more common after rupture of the mem
118 Lower endotoxin doses induced indicators of chorioamnionitis, lung and systemic inflammation without
119 rom an associated chronic or acute bacterial chorioamnionitis marked by the migration of HIV-1-infect
120 benefits of treating genital ulcer disease, chorioamnionitis, mastitis, and malnutrition in HIV-infe
121 risk of cerebral palsy: multiple gestation, chorioamnionitis, maternal antibiotics, antepartum vagin
122 her hand, a recent study also suggested that chorioamnionitis may increase the risk of recurrent whee
123 proteomic profile in an experimental primate chorioamnionitis model that detected subclinical IAI in
125 MIA areas: inflammatory biomarkers (n = 13), chorioamnionitis (n = 18), other types of infections (n
129 ore likely than HIV-uninfected women to have chorioamnionitis (odds ratio [OR], 2.1; P=.03), placenta
135 if a treating physician made a diagnosis of chorioamnionitis or endometritis clinically, was noted i
136 intact membranes, suggesting that GBS cause chorioamnionitis or establish amniotic fluid infections
137 mortality and morbidity, often triggered by chorioamnionitis or intrauterine inflammation (IUI) with
140 ied in multiple logistic regression included chorioamnionitis (OR, 4.1; 95% CI, 1.6-10.1), intrauteri
141 with GG (OR, 2.4; 95% CI, 1.3-4.4), clinical chorioamnionitis (OR, 4.6; 95% CI, 2.1-10.4), maternal a
142 als predominantly exhibited mild to moderate chorioamnionitis (P<0.0001), and a significant reduction
143 m prelabor rupture of the membranes (pPROM), chorioamnionitis, perinatal loss, and perinatal morbidit
144 zation of oral bacteria or their antigens in chorioamnionitis placental tissue has never been demonst
146 m delivery, poor fetal growth, preeclampsia, chorioamnionitis, postpartum hemorrhage, stillbirth, and
151 ational-age (SGA) births (<10th percentile), chorioamnionitis, preterm birth (<37 weeks' gestation),
153 who transmitted infection to their child had chorioamnionitis (relative risk [RR], 0.2; P=.03), funis
154 nd the cervix and cause membrane rupture and chorioamnionitis, require new strategies for detection a
155 ison of preterm cases without and with acute chorioamnionitis revealed elevated CXCL9, CXCL10, CXCL11
156 inflammatory diseases, including histologic chorioamnionitis, sepsis, bronchopulmonary dysplasia, an
158 station, third-trimester maternal infection, chorioamnionitis, toxoplasmosis, other infections, rubel
159 term, preterm, small-for-gestational-age, or chorioamnionitis) using two independent gene expression
161 al diabetes, premature rupture of membranes, chorioamnionitis, venous thromboembolism, excessive feta
162 Cs) but not in interstitial trophoblasts, in chorioamnionitis versus gestational age-matched control
163 re significantly lower in choriodecidua from chorioamnionitis versus gestational age-matched controls
165 ancy (adjusted RR, 1.09; 95% CI, 0.99-1.20); chorioamnionitis was diagnosed in 6.1% of vaccinated and
168 0.9-2.7) in preterm infants, and histologic chorioamnionitis was significantly associated with cPVL
170 In a logistic regression model, histologic chorioamnionitis was the only independent predictor of t
171 re, placental macrophages from patients with chorioamnionitis were unable to form MGCs, but this defe
174 s a major determinant in ureaplasmal induced chorioamnionitis with fetal infection and fetal inflamma